TS

Thermo Fisher Scientific

TMO

NYSEHealth Care

Income Statement

Total Revenue$42.88B

Gross Profit$17.7B

Operating Income$7.34B

EBITDA$11.49B

EBIT$8.38B

Pre-tax Income$7.42B

Net Income$6.34B

Balance Sheet

Cash Equivalent$5.31B

Total Debt$34.4B

Book Value$47.86B

Book Value Per Share125.33

Key Ratios

Return on Equity (ROE)+12.78%

Return on Assets (ROA)+6.51%

Return on Invested Capital (ROI)+7.84%

Net Profit Margin+14.77%

Current Ratio1.66

Quick Ratio1.29

Long-Term Debt / Equity0.59